TearLab Enters Into Cooperative Marketing Agreement With Abbott Medical Optics’ Canadian Subsidiary

SAN DIEGO, Aug. 31, 2010 (GLOBE NEWSWIRE) — TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) today announced that it has entered into a cooperative marketing agreement with Abbott Medical Optics Inc.’s subsidiary, AMO Canada Company (“AMO Canada"). Under the agreement, AMO Canada’s sales force will directly sell the TearLab™ Osmolarity System in Canada while TearLab will help promote AMO Canada’s products for the relief of dry eye symptoms, including Blink® Moisturizing Eye Drops. Financial terms were not disclosed.